SCHEMBL109117

SCHEMBL109117

CC(C)CCCCCCCCOC(=O)c1ccc(C(=O)OCCCCCCCCC(C)C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
NPC1 O15118 1/20 0.57
MAPT P10636 1/20 0.57
RAB9A P51151 1/20 0.57
MAPK1 P28482 2/20 0.56
PKM P14618 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 2/20 0.56
TSHR P16473 3/20 0.53
LMNA P02545 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
ESR1 P03372 2/20 0.53
CYP2D6 P10635 1/20 0.53
NR1H2 P55055 1/20 0.53
RNASEL Q05823 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
RARB P10826 1/20 0.53
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9246141 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL111217 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL111402 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL9615305 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL111533 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL108369 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL109442 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL30060305 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL16274557 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1
SCHEMBL110550 1.00 ALDH1A1 (0.57) ALDH1A1NPC1MAPTRAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220314514-A1 MOISTURE-CURABLE ADHESIVE COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY 2022-10-06 US claimed
EP-1567470-B1 HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF EXXONMOBIL CHEM PATENTS INC (US) 2013-06-05 EP claimed
US-7875742-B2 hydrogenating organic compounds by contacting with hydrogen-containing gas in presence of catalyst which comprises catalytically active metals applied to porous catalyst support; catalytically active metals having been derived via decomposed amine complex of metal on support EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-01-25 US claimed
US-20100184895-A1 Hydrogenation Processes EXXONMOBOIL RESEARCH AND ENGINEERING COMPANY 2010-07-22 US claimed
US-7595420-B2 Hydrogenation of benzene polycarboxylic acids or derivatives thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2009-09-29 US claimed
US-20060247461-A1 Hydrogenation of benzene polycarboxylic acids or derivatives thereof EXXONMOBIL CHEMICAL PATENTS INC. 2006-11-02 US claimed
EP-1567470-A1 HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF ExxonMobil Chemical Patents Inc. (US) 2005-08-31 EP claimed
WO-2004046078-A1 HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-06-03 WO claimed
CN-110914232-B Process for hydrogenating aromatic compounds 巴斯夫欧洲公司 2023-03-14 CN disclosed
EP-3769932-B1 MOISTURE-CURABLE ADHESIVE COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-02-15 EP disclosed
US-20220314514-A1 MOISTURE-CURABLE ADHESIVE COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY 2022-10-06 US disclosed
EP-3589707-B1 COATING COMPOSITION COMPRISING PVC AND PLASTICIZERS BASF SE (DE) 2022-10-05 EP disclosed
CN-114144492-A Moisture curable adhesive composition 3M创新有限公司 2022-03-04 CN disclosed
US-11203566-B2 Hydrogenation of aromatic compounds BASF SE (DE) 2021-12-21 US disclosed
US-20060149097-A1 Hydrogenation processes EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2006-07-06 US disclosed
EP-1578712-A2 HYDROGENATION CATALYST, PREPARATION THEREOF AND HYDROGENATION PROCESSES USING THIS CATALYST ExxonMobil Research and Engineering Company (US) 2005-09-28 EP disclosed
EP-1567470-A1 HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF ExxonMobil Chemical Patents Inc. (US) 2005-08-31 EP disclosed
WO-2004046076-A2 HYDROGENATION CATALYST, PREPARATION THEREOF AND HYDROGENATION PROCESSES USING THIS CATALYST EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2004-06-03 WO disclosed
WO-2004046078-A1 HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-06-03 WO disclosed
EP-0881065-A1 THREE-LAYER STRUCTURE, POLYOLEFIN MOLDING, AND PROCESSES FOR THE PRODUCTION OF BOTH SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1998-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060149097-A1 Hydrogenation processes HAO2, HVCN1, AOC3 ALDH1A1 1483/4885NPC1 3101/4885MAPT 3739/4885
US-20100184895-A1 Hydrogenation Processes HAO2, HVCN1, AOC3 ALDH1A1 1483/4885NPC1 3101/4885MAPT 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.